Common use of Study Performance Clause in Contracts

Study Performance. 1.1 PROTOCOL Subject to approval of the Study pursuant to Section 1.2 below, Principal Investigator agrees to conduct to the extent funds are made available hereunder a clinical study of a 308nm Excimer Laser manufactured by Acculase, Inc., a subsidiary of Laser Photonics, Inc. (hereinafter referred to as the "Study Device") in accordance with the study protocol entitled "308 nm Excimer Laser for the Treatment of Vitiligo: A Pilot Study", a copy of which is attached hereto as Exhibit A (hereinafter referred to as the "Study"). In the event of any conflict between Exhibit A and the provisions of this Agreement, the provisions of this Agreement shall govern.

Study Performance. 1.1 PROTOCOL Subject to approval of the Study pursuant to Section 1.2 below, Principal Investigator agrees to conduct to the extent funds are made available hereunder a clinical study of a 308nm Excimer Laser manufactured by Acculase, Inc., a subsidiary of Laser Photonics, Inc. (hereinafter referred to as the "Study Device") in accordance with the study protocol entitled "308 nm Excimer Excimir Laser for the Treatment of Vitiligo: A Pilot StudyPlaque Psoriasis (4MED/6MED)", a copy of which is attached hereto as Exhibit A (hereinafter referred to as the "Study"). In the event of any conflict between Exhibit A and the provisions of this Agreement, the provisions of this Agreement shall govern.

Study Performance. 1.1 PROTOCOL Subject to approval of the Study pursuant to Section 1.2 below, Principal Investigator agrees to conduct to the extent funds are made available hereunder a clinical study of a 308nm Excimer Laser manufactured by Acculase, Inc., a subsidiary of Laser Photonics, Inc. (hereinafter referred to as the "Study Device") in accordance with the study protocol entitled "Pilot Study to Determine the Safety and Efficacy of the 308 nm Excimer Laser for the Treatment of Vitiligo: A Pilot StudyScalp Psoriasis", a copy of which is attached hereto as Exhibit A (hereinafter referred to as the "Study"). In the event of any conflict between Exhibit A and the provisions of this Agreement, the provisions of this Agreement shall govern.

Study Performance. 1.1 PROTOCOL Subject to approval of the Study pursuant to Section 1.2 below, Principal Investigator agrees to conduct to the extent funds are made available hereunder a clinical study of a 308nm Excimer Laser manufactured by Acculase, Inc., a subsidiary of Laser Photonics, Inc. (hereinafter referred to as the "Study Device") in accordance with the study protocol entitled "308 nm Excimer Laser for the Treatment of Vitiligo: A Pilot Plaque Psoriasis (High Fluence Study)", a copy of which is attached hereto as Exhibit A (hereinafter referred to as the "Study"). In the event of any conflict between Exhibit A and the provisions of this Agreement, the provisions of this Agreement shall govern.